Publications
73
Citations
1,443
Est. group size
~1
Recurring co-author estimate
Active years
21
Publishing since 2006
Yu-Jung Jenny Wei's research uses large healthcare databases, especially Medicare and nursing home records, to study the safety and effectiveness of opioid pain medications in older adults. A major focus is understanding how drug interactions (such as with antidepressants or gabapentinoids) and genetic differences in drug metabolism (CYP2D6) affect risks like overdose, falls, seizures, and cognitive decline. This work aims to inform safer prescribing practices for chronic pain and opioid use disorder treatment in vulnerable, elderly populations.
Publication output has fluctuated over the past decade with peaks around 2019, 2021, and 2024-2025, suggesting an active but variable rather than steadily growing pace of output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Pain and treatment outcomes after initiating methadone vs buprenorphine among medicare patients with opioid use disorder and comorbid chronic pain: A target trial emulation
PLoS Medicine · 2026
- Clinical outcomes associated with drug–drug interactions involving buprenorphine: a systematic review
Addiction Science & Clinical Practice · 2026
- Predictive Models for Time to First Opioid Use Disorder or Opioid Overdose Among Older Adults
Journal of General Internal Medicine · 2026
- <i>CYP2D6</i> Phenotypes and Emergency Department Visits Among Patients Receiving Opioid Treatment
JAMA Network Open · 2025
- Association of initiating CYP2D6-metabolized opioids with risks of adverse outcomes in older adults receiving antidepressants: A retrospective cohort study
PLoS Medicine · 2025
- Prescription opioid use and cognitive function in older adults with chronic pain: A population‐based longitudinal cohort study
Alzheimer s & Dementia · 2025
- Risk of Seizure Associated With Concomitant Use of Tramadol and Antidepressants in Older Nursing Home Residents
Neurology · 2025
- Use of<scp>CYP2D6</scp>Inhibitors with<scp>CYP2D6</scp>Opioids: Association with Emergency Department Visits for Pain
Clinical Pharmacology & Therapeutics · 2024
- Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study
Drug Safety · 2024
- Clinical and Adverse Outcomes Associated With Concomitant Use of CYP2D6-Metabolized Opioids With Antidepressants in Older Nursing Home Residents
Annals of Internal Medicine · 2024
- Short- and long-term safety of discontinuing chronic opioid therapy among older adults with Alzheimer’s disease and related dementia
Age and Ageing · 2024
- Abstract 2249: Clinical outcomes of discontinuing long-term opioid therapy among older cancer survivors in nursing homes
Cancer Research · 2024
- Clinical and Adverse Outcomes Associated with Concomitant Use of CYP2D6-Metabolized Opioids with Antidepressants in Older Nursing Home Residents
Journal of Pain · 2024
- EPH16 Changes in Neutropenia Outcomes Following Implementation of the Clozapine Risk Evaluation and Mitigation Strategy Update
Value in Health · 2024
- Trends in Dietary Vitamin A Intake Among US Adults by Race and Ethnicity, 2003-2018
JAMA · 2023
- PLoS Medicine×6
- Clinical Pharmacology & Therapeutics×2
- Diabetes Care×2
- JAMA×2
- JAMA Network Open×2
- Justin Kullgren
Medicine · The Ohio State University
- Siegfried Schmidt
Medicine · The Ohio State University
- Lisa Mostafavifar
Medicine · The Ohio State University
- Jeffrey T. Boon
Medicine · The Ohio State University
- Alison R. Anderson
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile